Amedisys Cash Flow - Annual (NASDAQ:AMED)

Add to My Stocks
$93.99 $1.02 (1.07%) AMED stock closing price Jul 13, 2018 (Closing)

The Amedisys cash flow statement is one of the three reports that the company generates every quarter. While its important to look at the Amedisys debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Amedisys revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. This statement can tell if a company is running out of money while still being profitable and is useful in Amedisys stock analysis. Amedisys had a positive net income cash flow of $30.68M for the latest 2017. This report is very useful in measuring the short term viability of a company. Amedisys has a positive cash and cash equivalents change of $56.16M.

View details of Amedisys cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow17.85M20.41M20.99M32.25M47.57M203.6M621.09M36.16M29.88M21.61M
Net Increase (Decrease) in Assets Liabilities-48.35M-67.07M-18.34M-12.76M27.34M-45.24M-7.27M-23.68M13.43M-30.23M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net105.54M71.28M107.44M-98.11M125.12M9.72M-89.81M80.52M68.11M72.67M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-10.45M-15.71M-1.44M-11.99M-39.79M-47.31M-43.43M-61.33M-35.36M-27.75M
Acquisition Disposition of Subsidiaires-33.71M-35.52M-68.71M4.23M3.51M-12.49M-132.23M-3.82M-53.57M-471.31M
Increase (Decrease) in Investments-0.47M-1.04M1.51M-6.4M-10.06M--4.5M-5M--
Other Cash Inflow (Outflow) from Investment Activities--1.22M-0.13M-0.11M-0.17M-0.54M-3.46M-8.32M-6.57M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--9.83M-1.97M2.99M3.44M4.06M5.39M-4.09M9.11M6.65M
Issuance (Repayment) of Debt Securities-5.31M-5M-3M54.34M-55.8M-44.44M-37.48M-44.83M-44.33M295.58M
Increase (Decrease) in Bank & Other Borrowings---15M15M-----80.5M-
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.21M7.31M-0.91M-1.78M-0.68M-2.58M-1.15M2.08M-3.04M-0.66M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year30.19M27.5M8.03M17.3M14.54M48M120.29M34.48M2.84M56.19M
Cash & Equivalents at Year End86.36M30.19M27.5M8.03M17.3M14.54M48M120.29M34.48M2.84M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Amedisys stock comparison chart provides an easy way to compare the stock price with peers along with details of Amedisys stock price history.
The statement of cash flows can be categorized into three main sections:

  • Amedisys has cash of $86.36M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Amedisys stock price.
  • Cash Flow from operating activities: Amedisys reported a positive operating cash flow of $105.73M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-44.02M for AMED stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-5.53M for Amedisys. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Amedisys Cash Flow

FCF margin